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myotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative condition characterized by
motoneuron degeneration and muscle paralysis.
Although the precise pathogenesis of ALS remains un-
clear, mutations in Cu/Zn superoxide dismutase (SOD1)
account for 
 
 
 
20–25% of familial ALS cases, and trans-
genic mice overexpressing human mutant SOD1 develop
an ALS-like phenotype. Evidence suggests that defects in
axonal transport play an important role in neurodegen-
eration. In 
 
Legs at odd angles
 
 (
 
Loa
 
) mice, mutations in
the motor protein dynein are associated with axonal
transport defects and motoneuron degeneration. Here,
A
 
we show that retrograde axonal transport defects are
already present in motoneurons of SOD1
 
G93A
 
 mice
during embryonic development. Surprisingly, crossing
SOD1
 
G93A
 
 mice with 
 
Loa
 
/
 
 
 
 mice delays disease pro-
gression and signiﬁcantly increases life span in 
 
Loa
 
/
SOD1
 
G93A
 
 mice. Moreover, there is a complete recovery
in axonal transport deﬁcits in motoneurons of these
mice, which may be responsible for the amelioration of
disease. We propose that impaired axonal transport is
a prime cause of neuronal death in neurodegenerative
disorders such as ALS.
 
Introduction
 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative
condition characterized by progressive motoneuron degeneration
(Brown, 1995; Shaw, 1999; Cleveland and Rothstein, 2001;
Rowland and Shneider, 2001). Although the precise etiology of
the disease remains unclear, mutations in the enzyme Cu/Zn
superoxide dismutase (SOD1) are responsible for 
 
 
 
20% of
familial ALS cases (Rosen et al., 1993), and transgenic mice
overexpressing human mutant SOD1 develop an ALS-like phe-
notype (Gurney et al., 1994; Wong et al., 1995). The pathologi-
cal mechanisms that cause selective motoneuron degeneration
in ALS remain unclear, but evidence suggests that disruptions
in axonal transport may play a significant role (Williamson and
Cleveland, 1999; Rao and Nixon, 2003; Jablonka et al., 2004).
Indeed, defects in anterograde axonal transport are one of the
earliest pathologies observed in SOD1 mice (Williamson and
Cleveland, 1999).
Cytoplasmic dynein is a molecular motor involved in ret-
rograde axonal transport along microtubules (Goldstein and
Yang, 2000) and plays a central role in motoneuron survival.
Mice with a mutation in the dynein heavy chain (
 
Dnchc1
 
 mutants
termed 
 
Legs at odd angles
 
 mice [
 
Loa
 
]) show defects in retro-
grade axonal transport and motoneuron survival (Hafezparast
et al., 2003). Inhibition of dynein-mediated axonal transport,
by postnatal overexpression of the motor-protein dynamitin,
also results in motoneuron degeneration (LaMonte et al.,
2002). Furthermore, mutations in dynactin, a motor protein in-
volved in dynein-mediated transport, have been identified in
families with slowly progressive forms of ALS (Puls et al.,
2003; Munch et al., 2004). Defects in dynein-dependent trans-
port also reduce trafficking of activated Trks, resulting in de-
generation of sensory neurons (Heerssen et al., 2004). Thus,
impairments of dynein-mediated axonal transport result in neu-
ron degeneration, although some reports suggest that impaired
axonal transport may be beneficial (Couillard-Despres et al.,
1998; Williamson et al., 1998; Kong and Xu, 1999, 2000).
We studied the consequences of crossing 
 
Loa
 
 mice bear-
ing a mutation in cytoplasmic dynein with SOD1
 
G93A
 
 mice. We
examined whether interaction between mutant SOD1 and the
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dynein mutation would affect disease progression and life span
in double-heterozygote (
 
Loa
 
/SOD1
 
G93A
 
) mice.
 
Results and discussion
 
Loa heterozygote female mice (
 
n
 
 
 
 
 
 12) were crossed with
SOD1
 
G93A
 
 males (
 
n
 
 
 
 
 
 10), producing four genetically distinct
groups of littermates: wild-type (WT), Loa heterozygotes,
SOD1
 
G93A
 
 hemizygotes, and Loa/SOD1
 
G93A
 
 double heterozy-
gotes. All mice were identified by genotyping for mutations in
the 
 
Dnchc1
 
 gene (
 
Loa
 
 mutation) and the human SOD1 trans-
gene, performed at 21 d and repeated in adults (
 
 
 
120 d).
We examined whether the mutation in cytoplasmic
dynein, inherited from Loa mice, altered the life span of
SOD1
 
G93A
 
 mice (Fig. 1 a). As previously reported, Loa/
 
 
 
mice had a normal life span (Hafezparast et al., 2003) and
SOD1
 
G93A
 
 mice a significantly reduced life span of only 125 d
(
 
 
 
 2.5 SEM, 
 
n
 
 
 
 
 
 20), with disease end-stage defined as a loss
of the righting reflex and 20% body weight. Surprisingly,
 
Loa
 
/SOD1
 
G93A
 
 mice lived for 160 d (
 
 
 
 3.1 SEM, 
 
n
 
 
 
 
 
 18), an
increase in life span of 28% (P 
 
 
 
 0.001). Disease onset was
also delayed in 
 
Loa
 
/SOD1
 
G93A
 
 mice (see Online supplemental
material for description of disease progression and Videos
1 and 2; available at http://www.jcb.org/cgi/content/full/
jcb.200501085/DC1) with a significant delay in the loss of
body weight (Fig. 1 b).
In view of this delay in disease onset and increased life
span of Loa/SOD1
 
G93A
 
 mice, we examined the heritability and
phenotype of the mutant SOD1 transgene from the 
 
Loa
 
/
SOD1
 
G93A
 
 double-heterozygous animals by breeding 
 
Loa/
 
 
 
 fe-
males with 
 
Loa
 
/SOD1
 
G93A
 
 males. SOD1
 
G93A
 
 progeny from this
cross showed the same phenotype as SOD1
 
G93A
 
 mice from the
regular F1 (C57BL/6 
 
 
 
 SJL) hybrid background, with no dif-
ference in life span (P 
 
 
 
 0.05; Achilli et al., 2005).
The expression of the human SOD1 protein was examined
to ensure that the breeding protocol had not altered the expres-
sion levels of the SOD1 transgene. Spinal cords from each
group were processed for immunocytochemistry and quantita-
tive Western blot analysis (Fig. 1, c–e). Human SOD1 was only
present in spinal cords of SOD1
 
G93A
 
 and 
 
Loa
 
/SOD1
 
G93A
 
 mice,
and not WT or 
 
Loa/
 
 
 
 littermates, as would be predicted by their
genotype. Expression levels of human SOD1 in the 
 
Loa
 
/
SOD1
 
G93A
 
 mice and their SOD1
 
G93A
 
 littermates were quantified
by chemifluorescence (ECF) and chemiluminescent (ECL) sys-
tems followed by scanning for fluorescence and image analysis,
using mouse SOD1 proteins and proliferating cell nuclear anti-
gen (PCNA) as internal standards. We compared the relative
fluorescence ratios of mutant SOD1 over mouse SOD1 or
PCNA in each genotype with that of the other genotypes. There
were no significant differences in these ratios, indicating that the
expression levels of the mutant SOD1 protein in each group of
mice was the same and was not reduced in 
 
Loa
 
/SOD1
 
G93A
 
 mice.
Disease phenotype and progression in each group of
mice was also examined by in vivo physiological analysis of
extensor digitorum longus (EDL), an ankle flexor muscle, in
120-d-old mice (Fig. 2). In 
 
Loa
 
/
 
 
 
 mice at this stage EDL
muscles produce a normal force, but in SOD1
 
G93A
 
 mice they
are significantly weaker (P 
 
 
 
 0.05). Surprisingly, in 
 
Loa
 
/
Figure 1. Life span, weight loss, and expression of human SOD1 transgene. The graphs show (a) the increase in life span and (b) delayed loss of
body weight in the Loa/SOD1
G93A mice (n   18–20). Examples of spinal cord sections from SOD1
G93A and Loa/SOD1
G93A mice (c and d, respectively)
immunostained for human SOD1 (bar   70  m). (e) A representative Western blot of human SOD1 using brain tissue. 
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SOD1
 
G93A
 
 mice the muscles are as strong as in WT mice (P 
 
 
 
0.213). Furthermore, changes in the contractile characteristics
of EDL that occur during disease progression in SOD1
 
G93A
 
mice (Kieran et al., 2004) do not occur in 
 
Loa
 
/SOD1
 
G93A
 
 mice
at this age. EDL is normally a fast-contracting muscle that fa-
tigues rapidly when repeatedly stimulated, producing a char-
acteristic fatigue pattern from which a fatigue index (F.I.) can
be calculated. A F.I. approaching 1.0 indicates that a muscle is
very fatigable. As can be seen in Fig. 2 and Table I, these char-
acteristics change dramatically in SOD1
 
G93A
 
 mice, and by 120 d
EDL is a slow, fatigue-resistant muscle. These changes are
reflected in alterations in the histochemical properties of the
muscle fibers, which show an increase in oxidative capacity,
staining darkly for the oxidative enzyme succinate dehydroge-
nase (Fig. S1, a–d; available at http://www.jcb.org/cgi/content/
full/jcb.200501085/DC1). In contrast, in 120-d 
 
Loa
 
/SOD1
 
G93A
 
mice EDL retains its normal contractile and fatigue character-
istics, with no change in muscle fiber phenotype.
These improvements in muscle function in 
 
Loa
 
/SOD1
 
G93A
 
mice are reflected in an increase in motor unit survival. Exam-
ples of motor unit traces from EDL are shown in Fig. 3, a–d,
and mean motor unit survival is summarized in Fig. 3 e. In WT
mice, 28 motor units (
 
 
 
 0.6 SEM, 
 
n
 
 
 
 
 
 6) innervate EDL, which
is the same in 
 
Loa/
 
 
 
 mice (27 
 
 
 
 0.7 SEM, 
 
n
 
 
 
 
 
 6). In 120-d
SOD1
 
G93A
 
 mice only 11 (
 
 
 
 0.9 SEM, 
 
n
 
 
 
 
 
 6) motor units sur-
vive, but in 
 
Loa
 
/SOD1
 
G93A
 
 mice there is a significant increase in
motor unit number, and 27 (
 
 
 
 1.1 SEM, 
 
n
 
 
 
  6) survive.
There was also a significant increase in motoneuron sur-
vival in spinal cords of Loa/SOD1
G93A mice (Fig. 4). In 120-d
SOD1
G93A mice only 242 (  9.6 SEM, n   8) motoneurons sur-
vive in the segment of the sciatic motor pool examined, com-
pared with 608 (  12.7 SEM, n   8) in WT mice. In Loa/
SOD1
G93A mice there is a significant increase in motoneuron sur-
vival, and 560 (  15 SEM, n   8; P   0.001) survive. There is
no motoneuron loss in Loa/  mice at this stage. However, im-
munostaining of spinal cord sections for glial fibrillary astrocytic
protein (GFAP), an astrocyte marker and indicator of the gliosis
Figure 2. Muscle force and phenotype. (a) Maximum force generated by
EDL muscles (n   10–12) in each group at 120 d of age (g   grams).
Error bars   SEM. Fatigue traces from EDL muscles of (b) WT, (c) Loa/ ,
(d) SOD1
G93A, and (e) Loa/SOD1
G93A mice at 120 d of age (bar   30 s).
Figure 3. Motor unit survival. Examples of motor unit traces from EDL
muscles (n    10) in (a) WT, (b) Loa/ , (c) SOD1
G93A, and (d) Loa/
SOD1
G93A mice. (e) Mean motor unit survival in each group at 120 d of
age. Error bars   SEM.
Table I. Contractile and fatigue characteristics of EDL muscles
TTP 1/2 RT F.I.
ms ms
WT (n   10) 25.1   3.0 25.8   2.4 0.85   0.03
Loa/  (n   10) 31.2   2.3 32.4   3.9 0.82   0.04
SODG93A (n   12) 44.5   3.8 86.5   6.0 0.41   0.06
Loa/SODG93A (n   10) 27.8   1.0 30.0   3.8 0.72   0.04
Table I shows the time taken to reach maximum twitch force (time to peak, TTP),
the half-relaxation time (1/2 RT), and the fatigue index (F.I.) of EDL muscles of
mice from each cohort of littermates at 120 d of age. Values are   SEM.JCB • VOLUME 169 • NUMBER 4 • 2005 564
that occurs around degenerating motoneurons (Nagata et al.,
1998), showed that GFAP was up-regulated not only in spinal
cord of SOD1
G93A mice, but also Loa/SOD1
G93A mice, in which
no motoneuron death was observed at this time (Fig. S1, e–h).
Because the dynein mutation results in defects in retro-
grade axonal transport in motoneurons of Loa/Loa embryos
(Hafezparast et al., 2003), the present results suggest that the
onset and progression of disease in SOD1
G93A mice may be de-
layed by further disruption of retrograde axonal transport. To
examine whether retrograde axonal transport was altered in mo-
toneurons of Loa/SOD1
G93A mice, primary motoneuron cultures
from spinal cords of E13 littermate embryos of all four geno-
types were prepared (Arce et al., 1999) and analyzed using an in
vitro retrograde transport assay based on the carboxy-terminal
fragment of tetanus neurotoxin (TeNT HC; Lalli and Schiavo,
2002; Hafezparast et al., 2003; Lalli et al., 2003). This fragment
binds specifically to motoneurons and is recruited to a vesicular
compartment targeted to the cell body. TeNT HC carriers, which
use both cytoplasmic dynein and myosin Va for their retrograde
movement, are shared by both the NGF and the low affinity
neurotrophin receptor p75
NTR. For this in vitro retrograde
transport assay, motoneurons were incubated with Alexa 488–
labeled TeNT HC and the transport of the TeNT HC carriers was
monitored in real time (Fig. 5 a; Videos 3–6, available at http://
www.jcb.org/cgi/content/full/jcb.200501085/DC1). SOD
G93A
motoneurons displayed slower and fewer TeNT HC carriers than
WT,  Loa/ , and Loa/SOD1
G93A motoneurons (Table S1).
SOD1
G93A-derived TeNT HC carriers also show a higher fre-
quency of pauses (Fig. 5 a, arrows) and anterograde phases
(Fig. 5 a, arrowheads). The corresponding displacement graphs
derived from WT, Loa/ , SOD1
G93A, and Loa/SOD1
G93A moto-
neurons further confirmed differences in the dynamics of TeNT
HC carriers in SOD1
G93A and Loa/SOD1
G93A (Fig. 5 b; Fig. S2).
These differences were quantified by analyzing the speed distri-
bution profiles shown in Fig. 5 c, which were obtained from 144
carriers (1,488 single movements) from three WT embryos, 111
carriers (n   1,040) from three Loa/  embryos, 127 carriers
(n   1,630) from four SOD1
G93A embryos, and 144 carriers (n  
1,163) from two Loa/SOD1
G93A embryos (see Table S1). The
vast majority of movements of TeNT HC carriers are retrograde
and are shown conventionally as positive. Surprisingly, even at
E13, a relatively early stage of embryonic development, kinetic
analysis of this compartment revealed that motoneurons derived
from SOD1
G93A littermates already displayed an impairment of
retrograde transport (Fig. 5, b and c). In particular, SOD1
G93A
carriers are characterized by an increased frequency of pauses
and oscillatory movements (as shown by an increased rate of
events in the speed range of  0.2/0.2  m/s) and by a shift in
their speed profile toward lower values (Fig. 5 c; SOD1
G93A,
black line vs. WT, red line). Loa/  motoneurons displayed a
speed profile very similar to that seen in WT mice (Fig. 5 c,
blue line vs. red line; see also Fig. S2), suggesting that two cop-
ies of a mutated dynein heavy chain are required to observe the
dramatic alteration in retrograde transport previously detected
in Loa/Loa homozygous mice (Hafezparast et al., 2003). Sur-
prisingly, the deficit in carrier frequency and retrograde trans-
port observed in SOD1
G93A motoneurons is completely rescued
in Loa/SOD1
G93A cells in which we observed a decrease in
the frequency of pauses and a shift in the speed profile to-
ward higher values. (Fig. 5 c, Loa/SOD1
G93A, green line vs.
SOD1
G93A, black line; see also Fig. S2). This recovery went be-
yond expectation; the frequency of the carriers was increased
and retrograde transport speeds exceeded on average those ob-
served in WT motoneurons.
These results show that a defect in axonal transport is
present in motoneurons from SOD1
G93A embryos as early as 13 d
of gestation. This is one of the earliest reported changes associ-
ated with mutant SOD1 expression, and emphasizes the role
that disruptions in axonal transport may play in ALS pathogen-
esis. Surprisingly, this impairment in axonal transport in
SOD1
G93A motoneurons is completely rescued in motoneurons
of Loa/SOD1
G93A mice. Our results therefore indicate that ax-
onal transport defects play a critical role in motoneuron degen-
eration in SOD1
G93A mice and that rescuing these defects can
have a clear beneficial effect both on motor abilities and life
span. The unexpected improvement in Loa/SOD1
G93A mice
may occur by rescuing the balance between anterograde and
retrograde transport in double-heterozygote motoneurons.
Thus, the amelioration of disease in Loa/SOD1
G93A mice may
result from the restoration of axonal homeostasis (i.e., the equi-
librium between proximal versus peripheral cargo distribution),
or by rescuing an imbalance between positive and negative ax-
onal transport inputs. The modulation of negative retrograde
signals may be particularly important in SOD1
G93A mice, as
Figure 4. Motoneuron survival. Cross sections of spinal cord showing
motoneurons in the sciatic motor pools (dotted areas, magnified in insets)
from (a) WT, (b) Loa/ , (c) SOD1
G93A, and (d) Loa/SOD1
G93A littermates
at 120 d of age (n   8). Bar: 400  m (main panels), 200  m (insets).
(e) Mean motoneuron survival at 120 d of age. Error bars   SEM.A MUTATION IN DYNEIN EXTENDS THE LIFE SPAN OF ALS MICE • KIERAN ET AL. 565
Figure 5. Kinetic analysis of retrograde axonal transport. The kymographs show the traces of TeNT HC–positive compartments in motoneuron axons
from WT, Loa/ , SOD1
G93A, and Loa/SOD1
G93A primary cultures (a). The width of kymographs corresponds to 65  m of axon length. The relative
abundance of stationary and oscillating TeNT HC carriers is not related to their genotype. Arrows show paused carriers; arrowheads show anterograde
phases. See also Videos 3–6 (available at http://www.jcb.org/cgi/content/full/jcb.200501085/DC1). (b) Displacement of TeNT HC–positive com-
partments shown in panel a. The start of tracking for each carrier was set to time   0. (c) Speed distribution of the TeNT HC–positive carriers in moto-
neurons from WT, Loa/ , SOD1
G93A, and Loa/SOD1
G93A E13 embryos. Single movements of TeNT HC–488 carriers, which are described by their
progress between two consecutive frames, have been plotted against their frequency. Retrograde transport is conventionally shown as positive, antero-
grade as negative, and pauses during movement are grouped at 0  m/s. Error bars   SEM.JCB • VOLUME 169 • NUMBER 4 • 2005 566
suggested by the beneficial effects observed after peripheral
axotomy (Kong and Xu, 1999) or impairment of p75
NTR and
neurotrophin-dependent signaling cascades (Reichardt and
Mobley, 2004). Alternatively, it is possible that the dynein mu-
tation results in abnormal intracellular transport, which in turn
may change the interaction of mutant SOD1 with organelles
such as mitochondria, thus delaying cell death. Indeed, it has
been suggested that the recruitment of mutant SOD1 to spinal
cord mitochondria underlies mutant SOD1-mediated toxicity
(Liu et al., 2004). Moreover, mutant SOD1 can bind to mito-
chondria and form aggregates that recruit the anti-apoptotic
protein Bcl-2 (Pasinelli et al., 2004).
In common with many other neurodegenerative diseases,
the molecular processes responsible for neuronal death in ALS
remain largely unknown. Although the molecular mechanism
by which the dynein mutation induces amelioration in Loa/
SOD1
G93A mice is still under investigation, it is clear that the
specific impairment of the neuronal function of cytoplasmic
dynein rescues the defect observed in SOD1
G93A mice and pro-
duces a complete recovery of the axonal retrograde transport
defect. This in turn may be responsible for the dramatic delay
in disease progression and extension in life span observed in
Loa/SOD1
G93A mice.
Materials and methods
The experiments were performed under license from the UK Home Office
(Animals Scientific Procedures Act 1986), following local ethical review.
Breeding protocol
Loa/  heterozygote female mice (n   12) were crossed with SOD1
G93A
males (n   10) to produce four genetically distinct groups of littermates:
WT, Loa/  heterozygotes, SOD1
G93A hemizygotes, and Loa/SOD1
G93A
double-heterozygote mice (Achilli et al., 2005). All mice were identified
by genotyping for mutations in the Dnchc1 gene (Loa mutation; Hafez-
parast et al., 2003) and the human SOD1 transgene (Gurney et al.,
1994) from tail DNA.
Assessment of muscle force and motor unit number
At 120 d of age, mice were anesthetized (4.0% chloral hydrate solution,
1 ml/100 g body weight, i.p.) and prepared for in vivo assessment of mus-
cle force (Kieran and Greensmith, 2004). Isometric contractions were elic-
ited by stimulating the nerve to EDL using square-wave pulses of a 0.02-ms
duration and supramaximal intensity. Contractions were elicited by trains
of stimuli at a frequency of 20, 40, and 80 Hz. Twitch, maximum tetanic
tension, time to peak, and half-relaxation time values were measured. The
number of motor units in both EDL muscles was assessed by applying stim-
uli of increasing intensity to the motor nerve, resulting in stepwise incre-
ments in twitch tension, due to successive recruitment of motor axons.
Fatigue test
EDL muscles were stimulated at 40 Hz for 250 ms every second and the
contractions were recorded on a pen recorder (Multitrace 2; Lectromed).
The decrease in tension after 3 min of stimulation was measured and the
F.I. was calculated as (initial tetanic tension   tetanic tension after stimula-
tion)/initial tetanic tension. A F.I. approaching 1.0 indicates that the mus-
cle is very fatigable.
Muscle histochemistry
EDL muscles were snap frozen and 10- m serial cross sections were cut
and stained for succinate dehydrogenase activity.
Motoneuron survival
After transcardial perfusion with 4% PFA, the lumbar region of the spinal
cord was removed and serial 20- m transverse sections were cut and
stained with gallocyanin, a Nissl stain. The number of Nissl-stained moto-
neurons in the sciatic motor pool of every third section (n   60) between
the L2 and L5 levels of the spinal cord were counted. Only large, polygo-
nal neurons with a distinguishable nucleus and nucleolus and a clearly
identifiable Nissl structure were included in the counts.
Immunocytochemistry
Sections of spinal cord were immunostained with antibodies to human
SOD1 (1:500; Sigma-Aldrich) or glial fibrillary astrocytic protein (1:500;
DakoCytomation) using standard protocols.
Microscopy, image acquisition, and manipulation
Spinal cord and muscle sections were examined at RT (22 C) under a light
microscope (DMR; Leica) using Leica HC PL Fluotar objectives (10 /0.3,
20 /0.5 and 40 /0.7 magnification/NA). Images were captured using
a digital camera (E995; Nikon) and the images downloaded into Adobe
Photoshop CS. To optimize image contrast, Levels Adjustment operations
were performed, but no other image manipulations were made.
Western blots
Total protein was determined in brain and spinal cord homogenates. NCL-
SOD1 (Novocastra Laboratories Ltd.) and anti-PCNA (PC10, Santa Cruz
Biotechnology, Inc.) were used to detect mouse/human SOD1 and PCNA
proteins, respectively. For SOD1 protein quantification we used the ECF
and ECL systems followed by scanning for fluorescence by a Storm-840
scanner (Molecular Dynamics) in three Western blots. Once scanned,
the blots were analyzed using FragmeNT analysis software (Molecular
Dynamics). Mouse SOD1 and PCNA proteins were used as internal stan-
dards to compare the relative amount of mutant SOD1 in each genotype.
Statistical analysis
Statistical significance was assessed between groups using a Kruskal-Wallis
test followed by a Mann-Whitney U-test.
Axonal retrograde transport assay
Cysteine-tagged TeNT HC was labeled with AlexaFluor 488 maleimide
(Lalli et al., 2003), and contained 1.8 mol of dye per mol of TeNT HC.
Single embryo cultures enriched in motoneurons were obtained from E13
spinal cords, followed by DNase incubation and centrifugation through a
4% BSA cushion (Arce et al., 1999). This BSA solution was dialyzed for
24 h at 4 C against PBS and 48 h against Leibovitz-15 medium (GIBCO
BRL), pH 7.3, using Spectra/Por membranes with a 25-kD cut-off. Cells
were resuspended in complete medium, plated onto poly-D,L-ornithine/
laminin–coated 35-mm glass-bottom dishes (MatTek) at a density of
60,000 cells/plate, and maintained in culture for 5–7d. Three indepen-
dent litters were used for the isolation of motoneurons with the four geno-
types described. Motoneurons were incubated with 40 nM TeNT HC-Alexa
488 in complete medium for 30 min at 37 C, washed three times with
Dulbecco’s minimum essential medium without phenol red, riboflavin,
folic acid, and penicillin/streptomycin, and supplemented with 30 mM
Hepes-NaOH, pH 7.3. Cells were placed in a humidified chamber main-
tained at 37 C and were imaged every 5 s with an inverted microscope
(Diaphot 300; Nikon) equipped with a Nikon 100 , 1.3 NA Plan Fluor
oil-immersion objective. Carrier tracking was performed on time-lapse se-
quences using Motion Analysis software (Kinetic Imaging). Only moving
carriers that could be tracked for at least four time points were consid-
ered. The distance covered by a carrier between two consecutive frames
(referred to as a single movement) was used to determine its speed. In the
final analysis we only included embryos with 15 or more TeNT HC carri-
ers. Statistical analysis and curve fitting were performed using Microsoft
Excel. Kymographs were generated using MetaMorph (version 6.2r4) af-
ter rotation of the image stack to align the neuronal process vertically.
200 vertical single-line scans through the center of each process were
plotted sequentially for every frame in the time series.
Online supplemental material
The appearance of a number of observable disease features in each
group of mice is described in the online supplemental material. Fig. S1
shows the histopathogy of EDL muscles and spinal cord sections of WT,
Loa/ , SOD1
G93A, and Loa/SOD1
G93A littermates. Fig. S2 shows dis-
placement graphs of TeNT Hc carriers in axons of each cohort of litter-
mates. Table S1 details the kinetic parameters of TeNT Hc compartments
in motoneurons of each group of mice. Videos 1 and 2 show examples of
120-d SOD1
G93A and Loa/SOD1
G93A littermates, respectively. Videos 3–6
shows phase images and corresponding movies of TeNT HC carriers trans-
ported in motoneuron axons of mice from each group of mice. Online sup-
plemental material available at http://www.jcb.org/cgi/content/full/
jcb.200501085/DC1.A MUTATION IN DYNEIN EXTENDS THE LIFE SPAN OF ALS MICE • KIERAN ET AL. 567
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